{"id":18922,"date":"2021-10-06T09:25:16","date_gmt":"2021-10-06T13:25:16","guid":{"rendered":"https:\/\/medicarereport.org\/?p=18922"},"modified":"2021-10-06T09:25:16","modified_gmt":"2021-10-06T13:25:16","slug":"the-status-of-drug-price-reforms","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=18922","title":{"rendered":"The status of drug price reforms"},"content":{"rendered":"<p>Despite campaign promises to cut drug prices, the current administration has not coalesced around a plan as they seek to push through a massive spending bill that would fund domestic policy initiatives, including new and enhanced health care programs. Members of Congress are focused on Medicare drug spending and have supported a plan passed by the House last year that allows Medicare to negotiate prices. Read the attached article <a href=\"https:\/\/www.benefitspro.com\/2021\/10\/05\/will-drug-price-reforms-make-it-through-congress\/\">here\u2026.<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/12\/file000273509242Washington-Congress-Capitol-700x525.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-8962\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/12\/file000273509242Washington-Congress-Capitol-700x525-300x225.jpg\" alt=\"\" width=\"300\" height=\"225\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/12\/file000273509242Washington-Congress-Capitol-700x525-300x225.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/12\/file000273509242Washington-Congress-Capitol-700x525.jpg 700w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>Despite campaign promises to cut drug prices, the current administration has not coalesced around a plan as they seek to<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,10,6,15],"tags":[],"class_list":["post-18922","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-legislative-update","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18922"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18922\/revisions"}],"predecessor-version":[{"id":18923,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18922\/revisions\/18923"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}